- First patient treated in new heavy‑chain‑only antibody trial
- Novo Nordisk and AWS form AI partnership to speed drug discovery
- Kupando doses first patient in phase 1 trial
- First-in-class house dust mite allergy treatment now available in Scotland
- Increasing trial participation for new cancer treatments
- Ontologies – what do they have to do with pharma research?
- Fighting the stigmatization of monkeypox patients
- Mobilizing against monkeypox
- Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline and Johnson & Johnson: report
- Targeting GSK and AstraZeneca, Clovis lifts sinking Rubraca with broad ovarian cancer win
- 'Extreme disappointment': With FDA snub of Akebia's vadadustat, another oral anemia med bites the dust
- Senate blesses bill to wrest US supply chains from China's grasp, with pharma front and center